Congressional Budget Office Releases Prescription Drugs Spending, Use, and Pricing Report
Results from a recently released Congressional Budget Office (CBO) prescription drugs report found drops in net prices for prescriptions in [...]
Lower-cost Biosimilars Blocked from Market by Patent Thickets
A new study finds that only 6% of patents for biologic medicines are for key ingredients. In contrast, 42% cover [...]
Innovation and Value Initiative Welcomes 8 New Board Members
The Innovation and Value Initiative (IVI), a non-profit focused on advancing care through patient-centered value assessment, has elected 8 new [...]
Survey: PharmaVoice Wants Your Input on New Website
PharmaVoice has recently redesigned their website and wants your input. They have also launched their new daily newsletter. Pharmavoice features [...]
New Independent Directors Appointed by Syneos
Syneos Health has announced that it has appointed Barbara W. Bodem and Alfonso G. Zulueta to its Board of Directors. [...]
Rare Disease Clinical Outcome Assessment Consortium Announced by C-Path
The Critical Path Institute (C-Path) has launched its Rare Disease Clinical Outcome Assessment Consortium. The Consortium is a public-private collaborative [...]
Clarivate Releases 2022 Drugs to Watch List
Clarivate has released their 2022 Drugs to Watch list. The list includes seven experimental therapeutics in the pipeline that have [...]
ICER Releases Evidence Report for Type 2 Diabetes Drug Tirzepatide
The Institute for Clinical and Economic Review (ICER) has released their revised evidence report for Eli Lilly’s new type 2 [...]
Pfizer, Gilead, and Vertex Raise Prices on Blockbuster Drugs
Major pharmaceutical companies are hiking prices on their blockbuster drugs for 2022. Pfizer is spiking the price of its cancer [...]
Managed Healthcare Executive Releases 2022 State of the Industry Survey
Respondents expressed middling optimism towards improvements to the American healthcare industry in 2022, according to Managed Healthcare Executive’s 2022 State [...]
ISPOR Webinar: The Future of Biosimilars
Biosimilars are poised to increase access to otherwise expensive therapies, but legal and regulatory hurdles abound. In an ISPOR webinar [...]
Draft Ruling from CMS Suggests Narrow Coverage for Aduhelm
The Centers for Medicare & Medicaid Services (CMS) have released a draft ruling indicating it will only cover Biogen’s Alzheimer’s [...]
Upcoming Webinar: Getting Real with Real-World Evidence
Fierce Pharma and Databricks are hosting a webinar at 12 pm ET / 9 am PT, on Thursday, January 27th, [...]
2022 Dealmakers’ Intentions Survey Released
Syneos Health Consulting has released the results of its 2022 Dealmakers’ Intentions Survey. The survey’s finding indicated that IPO markets [...]
Amgen and Arrakis Therapeutics Announce Partnership to Develop RNA-targeting Oral Drugs
The biotech startup Arrakis Therapeutics has partnered with Amgen in a research collaboration to develop oral drugs that target disease-related [...]
Pfizer Shifts to Virtual Meetings and Cuts Sales Staff
Pfizer will lay off sales staff as they pivot towards virtual sales meetings with providers to adjust to changing provider [...]
Market Access Speed Makes the Differences for Pharma
Advances in science and legislative changes have accelerated drug discovery and approval in recent years. However, payers eye these drugs [...]
Cancer Patients Save Money on Medication Due to ‘Skinny Labeling’
A new study finds that applying a ‘skinny label’ to the generic cancer drug Gleevec made the medicine available for [...]
23andMe Begins Clinical Trial for Their First Drug
Clinical trials have begun for the now-ubiquitous DNA-testing company 23andMe’s new cancer drug. The immuno-oncology antibody, named 23ME-000610, targets solid [...]
FDA Approves New Heart Drug by Novartis
Novartis’s genetic drug Levqio was approved by the FDA in December, but hurdles remain for long-term sales. The drug, which [...]
Elevate Podcast Channel: Starting a Career in Medical Affairs
Beginning a new career in medical affairs is the topic of the November episode of the Elevate Podcast Channel by [...]
Medical Affairs Podcast: Increasing Diversity in Clinical Trials
A lack of participant diversity in clinical trials exacerbates health disparity by limiting the applicability of new drugs to marginalized [...]
Eli Lilly Purchases Rights to Develop Proteo-lipid Drug Delivery Systems
Eli Lilly has started a collaboration with Entos Pharmaceuticals to develop Proteo-lipid vehicles (PLVs) for drug delivery. Entos will receive [...]
Webinar: Strategies to Overcome CAR-T Cell Resistance During Cell Therapy
CAR-T cell therapy has shown great potential in certain lymphoma and leukemia patients. However, resistance to the CAR-T cells in [...]
JAMA Report Investigates Cost-effectiveness Studies for Cancer Drugs
In a new article in the Journal of the American Medical Association, researchers Alyson Haslam, PhD, Mark P. Lythgoe, MD, [...]